F S&P 500
5,118.00 +35.75 (+0.70%) F Dow Jones
38,332.00 +44.00 (+0.11%) F Nasdaq
17,743.25 +175.75 (+1.00%) E-mini Russell 2000 Index Futur
1,991.30 -1.90 (-0.10%) Petróleo
84.11 +0.54 (+0.65%) Oro
2,359.30 +16.80 (+0.72%)
TherapeuticsMD, Inc. (TXMD)
Fuera de horario:
TherapeuticsMD, Inc.
951 Yamato Road
Suite 220
Boca Raton, FL 33431
United States
561 961 1900
https://www.therapeuticsmd.com
Sector(es): Healthcare
Industria: Drug Manufacturers - Specialty & Generic
Empleados a tiempo completo: 1
Ejecutivos clave
| Nombre | Título | Pagar | Ejecutado | Año de nacimiento |
|---|---|---|---|---|
| Governor Thomas G. Thompson | Executive Chairman | 150k | N/D | 1942 |
| Mr. Marlan D. Walker J.D. | Chief Executive Officer | 1.13M | N/D | 1976 |
| Mr. Robert G. Finizio | Co-Founder | 7.51k | N/D | 1971 |
| Mr. Michael C. Donegan | Interim CFO & Chief Accounting Officer | 712.59k | N/D | 1968 |
| Ms. Daniella Silva | Chief Compliance Officer | N/D | N/D | 1986 |
| Mr. Benjamin Foulk | Vice President of Human Resources | N/D | N/D | 1970 |
| Mr. Bharat Warrier | Chief Manufacturing Officer | N/D | N/D | 1978 |
| Mr. Douglas Steelman | Vice President of Market Access | N/D | N/D | N/D |
| Ms. Dedra Lyden | Vice President of Strategic Partnerships & Initiatives | N/D | N/D | N/D |
Descripción
TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY, BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brand names. The company sells its prescription pharmaceutical products and prenatal vitamin products through wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.
Gestión corporativa
La calificación ISS Governance QuickScore de TherapeuticsMD, Inc. a partir del 1 de abril de 2024 es 5. Las puntuaciones principales son Auditoría: 9; Junta: 5; Derechos del accionista: 2; Compensación: 5.
